MarketInOut Stock Screener Log In | Sign Up
 

Polyrizon Ltd

NASDAQ • Healthcare • Biotechnology • Quote as of 10/16/2026 15:57
Polyrizon Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization25.69 mln
Float2.36 mln
Earnings Date11/30/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

89 / 100
Strongly outperforming

ROE

-21.55
Deeply negative

ROA

-21.14
Deeply negative

Business Description

Polyrizon is an Israeli biotech company that develops hydrogel nasal sprays designed to protect against allergens, viruses, and other airborne threats. Its core technology works by forming a protective barrier inside the nasal passage, trapping harmful particles before they can enter the body, while also enabling the targeted delivery of medical treatments through the nose. The company has several products in development, including nasal sprays aimed at blocking allergies, COVID-19, and influenza. Founded in 2005 and based in Ra'anana, Israel, Polyrizon holds proprietary rights to the technology behind its product line.

Key Fundamentals

EPS-5.31
ROE-21.55
ROIC-115
ROA-21.14
Interest Cover-1,820
EBITDA, mln-4.27
EV / EBITDA-1.54
EV / EBIT-1.44

Quote Details

Last 10.00
Change -0.01 (-0.1%)
Open 10.00
Volume 19,236
Turnover 192,360
Average Volume 24,007

Financial Ratios

Leverage Ratio1.02
Current Ratio36.37
Price / Book0.94
Price / Tangible Book1.04

Financial Strength

Piotroski F-Score 3 / 9
Short Ratio0.76
Short % of Float2.12

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 11.23% 97 / 100   
1 Month -9.34% 30 / 100   
2 Months -27.85% 19 / 100   
6 Months -12.36% 33 / 100   
1 Year 48.81% 92 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us